Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LEGN |
---|---|---|
09:32 ET | 10633 | 38.67 |
09:33 ET | 616 | 38.5 |
09:35 ET | 500 | 38.575 |
09:37 ET | 700 | 39.27 |
09:39 ET | 1360 | 39.57 |
09:42 ET | 2896 | 39.59 |
09:44 ET | 3752 | 39.05 |
09:46 ET | 650 | 38.97 |
09:48 ET | 700 | 39.06 |
09:50 ET | 800 | 38.89 |
09:51 ET | 245 | 39 |
09:53 ET | 3738 | 38.96 |
09:55 ET | 6009 | 38.89 |
09:57 ET | 200 | 38.93 |
10:00 ET | 100 | 38.87 |
10:02 ET | 2562 | 38.71 |
10:04 ET | 300 | 38.685 |
10:06 ET | 100 | 38.61 |
10:08 ET | 2255 | 38.64 |
10:09 ET | 300 | 38.605 |
10:11 ET | 1000 | 38.64 |
10:13 ET | 3794 | 38.595 |
10:15 ET | 2400 | 38.54 |
10:18 ET | 600 | 38.51 |
10:20 ET | 500 | 38.65 |
10:22 ET | 800 | 38.67 |
10:24 ET | 4299 | 38.5 |
10:26 ET | 13052 | 38.46 |
10:27 ET | 2500 | 38.47 |
10:29 ET | 500 | 38.51 |
10:31 ET | 2797 | 38.51 |
10:33 ET | 2488 | 38.625 |
10:36 ET | 400 | 38.645 |
10:38 ET | 1700 | 38.655 |
10:40 ET | 731 | 38.675 |
10:42 ET | 5460 | 38.715 |
10:44 ET | 1964 | 38.73 |
10:45 ET | 4667 | 38.64 |
10:47 ET | 300 | 38.62 |
10:49 ET | 300 | 38.62 |
10:51 ET | 500 | 38.61 |
10:54 ET | 2527 | 38.53 |
10:58 ET | 300 | 38.53 |
11:00 ET | 781 | 38.56 |
11:02 ET | 200 | 38.495 |
11:03 ET | 2717 | 38.41 |
11:05 ET | 4629 | 38.28 |
11:07 ET | 472 | 38.28 |
11:09 ET | 2083 | 38.36 |
11:12 ET | 1100 | 38.29 |
11:14 ET | 300 | 38.315 |
11:16 ET | 1073 | 38.27 |
11:18 ET | 2100 | 38.25 |
11:20 ET | 1000 | 38.17 |
11:21 ET | 5370 | 38.05 |
11:23 ET | 1400 | 38.02 |
11:25 ET | 6107 | 38.025 |
11:27 ET | 14001 | 38.09 |
11:30 ET | 1100 | 38.07 |
11:32 ET | 9033 | 38 |
11:34 ET | 1090 | 38 |
11:36 ET | 14215 | 38.08 |
11:38 ET | 19232 | 38.09 |
11:39 ET | 2239 | 38.09 |
11:41 ET | 300 | 38.07 |
11:43 ET | 800 | 38.085 |
11:45 ET | 6429 | 38.08 |
11:48 ET | 3600 | 38.07 |
11:50 ET | 400 | 38.09 |
11:52 ET | 5573 | 38.12 |
11:54 ET | 761 | 38.125 |
11:56 ET | 2200 | 38.09 |
11:57 ET | 3144 | 38.105 |
11:59 ET | 2501 | 38.09 |
12:01 ET | 9508 | 38.18 |
12:06 ET | 2800 | 38.21 |
12:08 ET | 200 | 38.225 |
12:10 ET | 1810 | 38.225 |
12:12 ET | 2020 | 38.42 |
12:14 ET | 2492 | 38.375 |
12:15 ET | 5297 | 38.28 |
12:17 ET | 2007 | 38.17 |
12:19 ET | 883 | 38.22 |
12:21 ET | 5174 | 38.28 |
12:24 ET | 571 | 38.3 |
12:26 ET | 550 | 38.3 |
12:28 ET | 580 | 38.3 |
12:30 ET | 849 | 38.3 |
12:32 ET | 5596 | 38.325 |
12:33 ET | 500 | 38.31 |
12:35 ET | 2134 | 38.31 |
12:37 ET | 1391 | 38.31 |
12:39 ET | 4755 | 38.3 |
12:42 ET | 2000 | 38.26 |
12:44 ET | 1100 | 38.23 |
12:46 ET | 1473 | 38.15 |
12:48 ET | 333 | 38.1 |
12:50 ET | 3204 | 38.16 |
12:51 ET | 2482 | 38.1 |
12:53 ET | 3542 | 38.05 |
12:55 ET | 1010 | 38.03 |
12:57 ET | 1002 | 38.09 |
01:00 ET | 1916 | 38.04 |
01:02 ET | 864 | 38.07 |
01:04 ET | 1672 | 38.06 |
01:06 ET | 2330 | 38.15 |
01:08 ET | 2400 | 38.18 |
01:09 ET | 779 | 38.18 |
01:11 ET | 600 | 38.18 |
01:13 ET | 3598 | 38.15 |
01:15 ET | 500 | 38.14 |
01:18 ET | 3024 | 38.14 |
01:20 ET | 1441 | 38.11 |
01:22 ET | 400 | 38.1 |
01:24 ET | 900 | 38.145 |
01:26 ET | 2380 | 38.125 |
01:27 ET | 1900 | 38.11 |
01:29 ET | 800 | 38.06 |
01:31 ET | 14574 | 38 |
01:33 ET | 100 | 38 |
01:36 ET | 786 | 38.05 |
01:38 ET | 924 | 38.03 |
01:40 ET | 1215 | 38.07 |
01:42 ET | 1641 | 38.1 |
01:44 ET | 28391 | 37.88 |
01:45 ET | 1200 | 37.88 |
01:47 ET | 8222 | 37.95 |
01:49 ET | 2198 | 37.92 |
01:51 ET | 846 | 37.95 |
01:54 ET | 25546 | 37.91 |
01:56 ET | 100 | 37.935 |
01:58 ET | 4600 | 37.88 |
02:00 ET | 1831 | 37.91 |
02:02 ET | 3101 | 37.87 |
02:05 ET | 2555 | 37.925 |
02:07 ET | 34709 | 37.93 |
02:09 ET | 3182 | 37.92 |
02:12 ET | 2950 | 38.02 |
02:14 ET | 1508 | 38.04 |
02:16 ET | 1100 | 38.04 |
02:18 ET | 2300 | 38.07 |
02:20 ET | 1434 | 38.13 |
02:21 ET | 3229 | 38.1218 |
02:23 ET | 700 | 38.12 |
02:25 ET | 4600 | 38.12 |
02:27 ET | 200 | 38.11 |
02:30 ET | 2300 | 38.09 |
02:32 ET | 2446 | 38.06 |
02:34 ET | 554 | 38.05 |
02:36 ET | 5284 | 38.13 |
02:38 ET | 1000 | 38.12 |
02:39 ET | 3035 | 38.1312 |
02:41 ET | 900 | 38.12 |
02:43 ET | 3776 | 38.215 |
02:45 ET | 2018 | 38.2 |
02:48 ET | 7323 | 38.16 |
02:50 ET | 1566 | 38.15 |
02:52 ET | 2942 | 38.11 |
02:54 ET | 4400 | 38.05 |
02:56 ET | 2274 | 38.015 |
02:57 ET | 300 | 38.015 |
02:59 ET | 29926 | 38.045 |
03:01 ET | 19910 | 37.94 |
03:03 ET | 400 | 37.89 |
03:06 ET | 4375 | 37.87 |
03:08 ET | 1987 | 37.97 |
03:10 ET | 32992 | 37.95 |
03:12 ET | 6451 | 37.92 |
03:14 ET | 9700 | 37.88 |
03:15 ET | 6100 | 37.85 |
03:17 ET | 1800 | 37.85 |
03:19 ET | 4892 | 37.84 |
03:21 ET | 12749 | 37.86 |
03:24 ET | 10944 | 37.86 |
03:26 ET | 1500 | 37.86 |
03:28 ET | 13745 | 37.86 |
03:30 ET | 951 | 37.87 |
03:32 ET | 10290 | 37.84 |
03:33 ET | 4310 | 37.72 |
03:35 ET | 15177 | 37.73 |
03:37 ET | 6774 | 37.71 |
03:39 ET | 13734 | 37.7 |
03:42 ET | 8544 | 37.775 |
03:44 ET | 7268 | 37.875 |
03:46 ET | 13551 | 37.76 |
03:48 ET | 8131 | 37.65 |
03:50 ET | 11863 | 37.75 |
03:51 ET | 15963 | 37.63 |
03:53 ET | 25215 | 37.64 |
03:55 ET | 27916 | 37.565 |
03:57 ET | 82366 | 37.45 |
04:00 ET | 263136 | 37.42 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Legend Biotech Corp | 6.9B | -19.6x | --- |
Ascendis Pharma A/S | 7.4B | -15.4x | --- |
Blueprint Medicines Corp | 5.7B | -42.8x | --- |
Madrigal Pharmaceuticals Inc | 6.6B | -12.1x | --- |
Cytokinetics Inc | 6.1B | -9.6x | --- |
ADMA Biologics Inc | 4.6B | 70.7x | --- |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.9B |
---|---|
Revenue (TTM) | $520.2M |
Shares Outstanding | 184.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.08 |
EPS | $-1.91 |
Book Value | $6.88 |
P/E Ratio | -19.6x |
Price/Sales (TTM) | 13.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -67.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.